Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2026-01-02 @ 2:43 AM
Study NCT ID:
NCT06951503
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-30
First Post:
2025-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III, Randomized, Controlled and Multi-center Study of AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Sponsor:
Akeso
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-01-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-07
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-23
First Submit QC Date:
None
Study First Post Date:
2025-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-23
Last Update Post Date:
2025-04-30
Last Update Post Date Type:
ACTUAL